The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pneumocystis


Psychiatry related information on Pneumocystis


High impact information on Pneumocystis


Chemical compound and disease context of Pneumocystis


Biological context of Pneumocystis


Anatomical context of Pneumocystis


Associations of Pneumocystis with chemical compounds


Gene context of Pneumocystis


Analytical, diagnostic and therapeutic context of Pneumocystis


  1. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. Medina, I., Mills, J., Leoung, G., Hopewell, P.C., Lee, B., Modin, G., Benowitz, N., Wofsy, C.B. N. Engl. J. Med. (1990) [Pubmed]
  2. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. Fischl, M.A., Richman, D.D., Grieco, M.H., Gottlieb, M.S., Volberding, P.A., Laskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Schooley, R.T. N. Engl. J. Med. (1987) [Pubmed]
  3. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. Hughes, W.T., Rivera, G.K., Schell, M.J., Thornton, D., Lott, L. N. Engl. J. Med. (1987) [Pubmed]
  4. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. Koziel, H., Eichbaum, Q., Kruskal, B.A., Pinkston, P., Rogers, R.A., Armstrong, M.Y., Richards, F.F., Rose, R.M., Ezekowitz, R.A. J. Clin. Invest. (1998) [Pubmed]
  5. National case-control study of Kaposi's sarcoma and Pneumocystis carinii pneumonia in homosexual men: Part 2.Laboratory results. Rogers, M.F., Morens, D.M., Stewart, J.A., Kaminski, R.M., Spira, T.J., Feorino, P.M., Larsen, S.A., Francis, D.P., Wilson, M., Kaufman, L. Ann. Intern. Med. (1983) [Pubmed]
  6. Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease. Velayos, F.S., Sandborn, W.J. Inflamm. Bowel Dis. (2004) [Pubmed]
  7. Influence of injection drug use behavior on reported antiretroviral therapy use among women in the HIV Epidemiology Research study: on-site versus referral care. Rompalo, A.M., Shah, N., Mayer, K., Schuman, P., Klein, R.S., Smith, D.K., Vlahov, D. J. Acquir. Immune Defic. Syndr. (2001) [Pubmed]
  8. Aerosolized pentamidine and Pneumocystis carinii pneumonia: patient compliance and outcomes. Bjornson, D.C., Oster, C.N., Cortese, L.M., Nelson, B.A. The Annals of pharmacotherapy. (1992) [Pubmed]
  9. Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia. Horowitz, H.W., Wormser, G.P. N. Engl. J. Med. (1999) [Pubmed]
  10. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group. El-Sadr, W.M., Murphy, R.L., Yurik, T.M., Luskin-Hawk, R., Cheung, T.W., Balfour, H.H., Eng, R., Hooton, T.M., Kerkering, T.M., Schutz, M., van der Horst, C., Hafner, R. N. Engl. J. Med. (1998) [Pubmed]
  11. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. Powderly, W.G., Finkelstein, D., Feinberg, J., Frame, P., He, W., van der Horst, C., Koletar, S.L., Eyster, M.E., Carey, J., Waskin, H. N. Engl. J. Med. (1995) [Pubmed]
  12. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS. Hughes, W., Leoung, G., Kramer, F., Bozzette, S.A., Safrin, S., Frame, P., Clumeck, N., Masur, H., Lancaster, D., Chan, C. N. Engl. J. Med. (1993) [Pubmed]
  13. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. Allegra, C.J., Chabner, B.A., Tuazon, C.U., Ogata-Arakaki, D., Baird, B., Drake, J.C., Simmons, J.T., Lack, E.E., Shelhamer, J.H., Balis, F. N. Engl. J. Med. (1987) [Pubmed]
  14. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. Fischl, M.A., Dickinson, G.M., La Voie, L. JAMA (1988) [Pubmed]
  15. Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial. Soo Hoo, G.W., Mohsenifar, Z., Meyer, R.D. Ann. Intern. Med. (1990) [Pubmed]
  16. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Wharton, J.M., Coleman, D.L., Wofsy, C.B., Luce, J.M., Blumenfeld, W., Hadley, W.K., Ingram-Drake, L., Volberding, P.A., Hopewell, P.C. Ann. Intern. Med. (1986) [Pubmed]
  17. Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome. Fischl, M.A., Dickinson, G.M. Ann. Intern. Med. (1986) [Pubmed]
  18. Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. Pottratz, S.T., Paulsrud, J., Smith, J.S., Martin, W.J. J. Clin. Invest. (1991) [Pubmed]
  19. Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis. Horowitz, H.W., Jorde, U.P., Wormser, G.P. Lancet (1992) [Pubmed]
  20. In vitro suicide inhibition of self-splicing of a group I intron from Pneumocystis carinii by an N3' --> P5' phosphoramidate hexanucleotide. Testa, S.M., Gryaznov, S.M., Turner, D.H. Proc. Natl. Acad. Sci. U.S.A. (1999) [Pubmed]
  21. Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim/sulfamethoxazole. Mustafa, M.M., Pappo, A., Cash, J., Winick, N.J., Buchanan, G.R. J. Clin. Oncol. (1994) [Pubmed]
  22. Co-trimoxazole administered for Pneumocystis carinii pneumonia prophylaxis does not interfere with saquinavir pharmacokinetics. Maserati, R., Villani, P., Cocchi, L., Regazzi, M.B. AIDS (1998) [Pubmed]
  23. Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions. Tesselaar, K., Arens, R., van Schijndel, G.M., Baars, P.A., van der Valk, M.A., Borst, J., van Oers, M.H., van Lier, R.A. Nat. Immunol. (2003) [Pubmed]
  24. Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. O'Riordan, D.M., Standing, J.E., Kwon, K.Y., Chang, D., Crouch, E.C., Limper, A.H. J. Clin. Invest. (1995) [Pubmed]
  25. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Achari, A., Somers, D.O., Champness, J.N., Bryant, P.K., Rosemond, J., Stammers, D.K. Nat. Struct. Biol. (1997) [Pubmed]
  26. Role of type I IFNs in pulmonary complications of Pneumocystis murina infection. Meissner, N.N., Swain, S., Tighe, M., Harmsen, A., Harmsen, A. J. Immunol. (2005) [Pubmed]
  27. Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Wang, J., Gigliotti, F., Maggirwar, S., Johnston, C., Finkelstein, J.N., Wright, T.W. Infect. Immun. (2005) [Pubmed]
  28. Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. Lau, W.K., Young, L.S. N. Engl. J. Med. (1976) [Pubmed]
  29. Prophylaxis against Pneumocystis carinii pneumonia in patients receiving azidothymidine. Flanigan, T., Shapiro, E., Graham, R. N. Engl. J. Med. (1987) [Pubmed]
  30. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. Bozzette, S.A., Sattler, F.R., Chiu, J., Wu, A.W., Gluckstein, D., Kemper, C., Bartok, A., Niosi, J., Abramson, I., Coffman, J. N. Engl. J. Med. (1990) [Pubmed]
  31. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Ezekowitz, R.A., Williams, D.J., Koziel, H., Armstrong, M.Y., Warner, A., Richards, F.F., Rose, R.M. Nature (1991) [Pubmed]
  32. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. Neese, L.W., Standing, J.E., Olson, E.J., Castro, M., Limper, A.H. J. Immunol. (1994) [Pubmed]
  33. TNF-alpha-dependent ICAM-1- and VCAM-1-mediated inflammatory responses are delayed in neonatal mice infected with Pneumocystis carinii. Qureshi, M.H., Cook-Mills, J., Doherty, D.E., Garvy, B.A. J. Immunol. (2003) [Pubmed]
  34. Granulocyte-macrophage colony stimulating factor and Pneumocystis carinii pneumonia in mice. Mandujano, J.F., D'Souza, N.B., Nelson, S., Summer, W.R., Beckerman, R.C., Shellito, J.E. Am. J. Respir. Crit. Care Med. (1995) [Pubmed]
  35. Synthesis, antifolate, and antitumor activities of classical and nonclassical 2-amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines. Gangjee, A., Vidwans, A., Elzein, E., McGuire, J.J., Queener, S.F., Kisliuk, R.L. J. Med. Chem. (2001) [Pubmed]
  36. Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from 7 different host species. Ma, L., Imamichi, H., Sukura, A., Kovacs, J.A. J. Infect. Dis. (2001) [Pubmed]
  37. A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome. Falloon, J., Kovacs, J., Hughes, W., O'Neill, D., Polis, M., Davey, R.T., Rogers, M., LaFon, S., Feuerstein, I., Lancaster, D. N. Engl. J. Med. (1991) [Pubmed]
  38. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. Dudley, M.E., Wunderlich, J.R., Yang, J.C., Sherry, R.M., Topalian, S.L., Restifo, N.P., Royal, R.E., Kammula, U., White, D.E., Mavroukakis, S.A., Rogers, L.J., Gracia, G.J., Jones, S.A., Mangiameli, D.P., Pelletier, M.M., Gea-Banacloche, J., Robinson, M.R., Berman, D.M., Filie, A.C., Abati, A., Rosenberg, S.A. J. Clin. Oncol. (2005) [Pubmed]
  39. Pneumocystis carinii pneumonia. Diagnosis by lung biopsy. Rosen, P.P., Martini, N., Armstrong, D. Am. J. Med. (1975) [Pubmed]
  40. In situ hybridization analysis of developmental stages of Pneumocystis carinii that are transcriptionally active for a major surface glycoprotein gene. Haidaris, P.J., Wright, T.W., Gigliotti, F., Fallon, M.A., Whitbeck, A.A., Haidaris, C.G. Mol. Microbiol. (1993) [Pubmed]
  41. Bidirectional effectors of a group I intron ribozyme. Liu, Y., Leibowitz, M.J. Nucleic Acids Res. (1995) [Pubmed]
WikiGenes - Universities